Publications by authors named "Helene Vellemans"

Claim this Profile
R
Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registry.
Timothy Devos, Dries Deeren, Koen Theunissen, Dominik Selleslag, Benjamin Bailly, Hélène Vellemans

Hematology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemophagocytic lymphohistiocytosis and disseminated toxoplasmosis after stem cell transplant.
Thibaut Renotte, Florian Belik, Gautier Detry, Elodie Collinge, Hélène Vellemans

Clin Microbiol Infect· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage monotherapy with venetoclax after failure from a single course of standard induction chemotherapy for acute myeloid leukaemia.
Pierre-Yves Sansen, Carlos Graux, Anne Sonet, Marc André, Chantal Doyen, Hélène Vellemans

Br J Haematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Unusual Case of HHV-8 Negative, Idiopathic, Multicentric Castleman Disease Following Chronic Lymphocytic Leukaemia.
Pierre-Yves Sansen, Hélène Vellemans, Julien Depaus, Caroline Fervaille, Benoit Krug

Eur J Case Rep Intern Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete Remission in a TEMPI Syndrome Treated with a Daratumumab, Lenalidomide, and Dexamethasone-Based Regimen: A Case Report.
Pierre-Yves Sansen, Luc Montfort, Anne Nanquette, Julien Depaus, Hélène Vellemans

Case Rep Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryptosporidiosis, an Uncommon Complication after Allogeneic Stem-Cell Transplantation.
Edwige Boulet, Carlos Graux, Anne Sonet, Julien Depaus, Hélène Vellemans

Case Rep Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation.
Clarisse Cazelles, Karim Belhadj, Hélène Vellemans, Vincent Camus, Elsa Poullot

Leuk Lymphoma· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry.
Timothy Devos, Violaine Havelange, Koen Theunissen, Stef Meers, Fleur Samantha Benghiat, Hélène Vellemans

Ann Hematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma.
Hélène Vellemans, Marc P E André

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2-Induced Severe Immune Thrombocytopenic Purpura.
Aurelien Gonze, Colin Hannesse, Nathalie Coppens, Helene Vellemans, Gisele Maury

J Med Cases· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis.
Dominique Penther, Pierre-Julien Viailly, Sylvain Latour, Pascaline Etancelin, Elodie Bohers, Hélène Vellemans

Genes Chromosomes Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis